InGenuityD (www.Ingenuityd.com), a special purpose spinoff from BioGenex (www.Biogenex.com) designs, develops, manufacturers and commercializes multiple Covid-19 related diagnostic products. InGenuityD's unique product line offer significant advantages like reduced testing turnaround time, cost, reduced need for skilled lab technicians, increased throughput, and reduced possibility of human errors. Our portfolio of products including RT-PCR direct, multiplex test for differentiation of flue and Covid19 infection.